Interface between Maternal Antibodies and Natural Challenge for Bovine Viral Diarrhea Virus (BVDV) in Holstein Heifers

Camila Costa Baccili, Natália Meirelles Sobreira, Bruno Toledo Silva, Edviges Maristela Pituco, Viviane Gomes

Abstract


Background: Newborn calves are agammaglobulinemic, immunosuppressed and immunologically immature at birth. The passive immune transfer is fundamental to protect calves against pathogens. The decay of maternal antibodies precedes the immune maturation at puberty enhancing the susceptibility of calves to infections caused by BVDV. Then, the objective of this research was to evaluate the interface between passive and active immunity for Bovine Viral Diarrhea Virus (BVDV) in Holstein dairy heifers in the first 13 months of age to detect susceptibility periods and establish prophylactic measures on prevention of Bovine Viral Diarrhea.

Materials, Methods & Results: Sera were analyzed from 585 heifers by serum neutralization (SN) and enzyme linked immunosorbent assay (ELISA) for the p80 protein of BVDV. Heifers were categorized according to their age by the month of life. Heifers were seropositive (100%) from 1st to 13th. Median of neutralizing antibodies (Ab) titers obtained from 1st up to 13th month were 316.2; 125.9; 63.1; 50.1; 50.1; 39.8; 63.1; 63.1; 39.8; 79.4, 100.0; 74.4; and 79.4, respectively. The neutralizing Ab titers obtained in 1st month were different of the values observed from 2nd until 13th (P < 0.001), furthermore the Ab titers from 2nd month was statistical different of 4th (P = 0.01) and 6th (P = 0.05). The frequencies (%) of positive heifers for p80 from 1st up to 13th were 24.7; 18.2; 10.4; 11.8; 73.3; 73.8; 72.4; 58.1; 45.9; 48.4; 46.2; 43.8 and 61.5, respectively. The correlation observed for neutralizing Ab titers and age was negative and weak (ρ= -0.299; P < 0.001). On the other hand, the correlation between positive heifers for p80 and age was positive and moderate (ρ= 0.319; P < 0.001).

Discussion: The newborn calves had higher titers of neutralizing antibodies than other age groups and some calves were seropositive for the p80 protein. This profile points to the transfer of maternal antibodies produced by vaccination and/or natural exposure to BVDV. The exposure of the cows to the inactivated and live virus stimulates the production of neutralizing antibodies to the structural proteins of the virus, particularly the glycoprotein E2, detected by the serum neutralization test. The titers of serum neutralizing antibodies and the frequencies of seropositive for p80 protein decreased gradually from the first to the 4-6th month of life due to the metabolization of maternal immunoglobulins acquired by ingestion of colostrum. Frequencies of seropositive animals for protein p80 increased from the fifth month of life, which is the same moment that was observed declined of neutralizing maternal antibody titers. The phase of higher frequency of p80 positive animals coincides with greater rates of Babesiosis and Anaplasmosis. This history could justify the importance of the BVDV immunodepression as a risk factor for concomitant diseases. In general, the neutralizing antibody titers increased after the peaks of positive reactions to the p80 protein, but this moment coincides with the primo-vaccination in calves. Therefore, it is not possible to state the origin of these antibodies. Correlations between ages and serologic tests are consistent with previous data reporting the decrease in antibody titers and increase of seropositive animals for p80 protein, from the first month of life to puberty. In conclusion, maternal neutralizing Ab titers had gradual decreased whereas the frequency of positive heifers for p80 had increased values. The inversion observed between the maternal antibody titers and the increase in antibody for p80 indicates the moment of greatest risk for natural infections caused by BVDV.


Keywords


maternal antibodies; Bovine Diarrhea Virus (BVD); serum neutralization test; p80 protein.

Full Text:

PDF

References


Bolin S.R. & Ridipath J.F. 1995. Assessment of protection from systemic infection or disease afforded by low to intermediate titers of passively acquired neutralizing antibody against bovine viral diarrhea virus in calves. American Journal Veterinary Research. 56(6): 755-759.

Chase C.C.L., Elmowalid G. & Yousif A.A.A. 2004. The immune response to bovine viral diarrhea virus: a constantly changing picture. Veterinary Clinics of North America: Food Animal Practice. 20(1): 95-114.

Chase C.C.L., Hurley D.J. & Reber A.J. 2008. Neonatal Immune Development in the Calf and Its Impact on Vaccine Response. Veterinary Clinics of North America: Food Animal Practice. 24(1): 87-104.

Chase C.C.L., Thakur N., Darweesh M., Morarie-Kane S.E. & Rajput M.K. 2015. Immune response to bovine viral diarrhea virus-looking at newly defined targets. Animal Health Research Reviews. 16(1): 4-14.

Cortese V.S. 2009. Neonatal Immunology. Veterinary Clinics of North America: Food Animal Practice. 25(1): 221-227.

Dancey C.P. & Reidy J. 2005. Análise de correlação: o r de Pearson. In: Estatística sem matemática para psicologia. Porto Alegre: Artmed, pp.178-216.

Ellis J., West K., Cortese V., Konoby C. & Weigel D. 2001. Effect of maternal antibodies on induction and persistence of vaccine-induced immune responses against bovine viral diarrhea virus type II in young calves. Journal American Veterinary Medical Association. 219(3): 351-356.

Falkenberg S.M., Johnson C., Bauermann F.V., McGill J., Palmer M.V., Sacco R.E. & Ridpath J.F. 2014. Changes observed in the thymus and lymph nodes 14 days after exposure to BVDV field strains of enhanced or typical virulence in neonatal calves. Veterinary Immunology Immunopathology. 160(1-2): 70-80.

Fulton R.W., Briggs R.E., Payton M.E., Confer A.W., Saliki J.T., Ridpath J.F., Burge L.J. & Duff G.C. 2004. Maternally derived humoral immunity to bovine viral diarrhea virus (BVDV) 1a, BVDV1b, BVDV2, bovine herpesvirus-1, parainfluenza-3 virus bovine respiratory syncytial virus, Mannheimia haemolytica and Pasteurella multocida in beef calves, antibody decline by half-life studies and effect on response to vaccination. Vaccine. 22(5-6): 643-649.

González A.M. Arnaiz I. Yus E. Eiras C. Sanjuán M. & Diéguez F.J. 2014. Evaluation of long-term antibody responses to two inactivated Bovine Viral Diarrhea Virus (BVDV) vacines. The Veterinary Journal. 199(3): 424-428.

Graham D.A., German A. Mawhinney K. & Goodall E.A. 2003. Antibody responses of naive cattle to two inactivated bovine viral diarrhoea virus vaccines, measured by indirect and blocking ELISAs and virus neutralization. Veterinary Record. 152(26): 795-800.

Menanteau-Horta A.M., Ames T.R. & Johnson D.W. 1985. Effect of maternal antibody upon vaccination with infectious bovine rhinotracheitis and bovine virus diarrhea vaccines. Canadian Journal Compendium Medical. 49(1): 10-14.

Nobiron I., Thompson I., Brownlie J. & Collins M.E. 2003. DNA vaccination against bovine viral diarrhea vírus induces humoral and cellular responses in cattle with evidence for protection against viral challenge. Vaccine. 21(1718): 2082-2092.

OIE-World Organization for Animal Health. 2015. Bovine viral diarrhea. In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.04.08_BVD.pdf. [Accessed February 2016].

Roth J.A., Kaeberle M.L. & Griffith R.W. 1981. Effects of bovine viral diarrhea virus infection on bovine polymorphonuclear leukocyte function. American Journal of Veterinary Research. 42(2): 244-250.




DOI: https://doi.org/10.22456/1679-9216.81177

Copyright (c) 2018 Camila Costa Baccili, Natália Meirelles Sobreira, Bruno Toledo Silva, Edviges Maristela Pituco, Viviane Gomes

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.